Joseph Kittah
Internal Medicine · Eau Claire, WINPI 1073768438
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,500 of the $7,515 with a category attached, or 73.2%. Intuitive Surgical accounts for 90.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $6,419 and has fallen 95.7% since, to $276 in 2025. Among internal medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $341.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Novo Nordisk$157
- AstraZeneca$136
- Lilly USA, LLC$126
- Johnson & Johnson$125
- Novartis$100
- plus $70 from 2 others
What the payments were for
- Travel & lodging$1,11215%
- Food & beverage$90412%
- Education$5,50073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $6,800 |
| Novo Nordisk | 3 | $157 |
| AstraZeneca | 1 | $136 |
| Lilly USA, LLC | 1 | $126 |
| Johnson & Johnson | 1 | $125 |
| Novartis | 1 | $100 |
| Philips North America LLC | 2 | $56 |
| Insmed, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,515 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 235 | $217,390 |
| Breo ElliptaFluticasone/Vilanterol | 171 | $113,100 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 68 | $45,906 |
| Spiriva HandihalerTiotropium Bromide | 67 | $43,959 |
| Spiriva RespimatTiotropium Bromide | 27 | $23,589 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 25 | $21,289 |
| SymbicortBudesonide/Formoterol Fumarate | 60 | $17,832 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 22 | $12,715 |
| Incruse ElliptaUmeclidinium Bromide | 26 | $12,136 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 67 | $10,867 |
| Atrovent HfaIpratropium Bromide | 15 | $10,571 |
| DuleraMometasone/Formoterol | 15 | $8,282 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 336 | $8,083 |
| Ventolin HfaAlbuterol Sulfate | 88 | $7,873 |
| Doxepin Hcl | 25 | $4,640 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaSymbicort | $136 | $17,83260 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,411 internal medicine providers in Wisconsin.
Other internal medicine in Eau Claire
- Michael SmithEau Claire$8K
- Jeremiah DeptaMilwaukee$723K
- James KuplicSheboygan$201K
- Erik StilpMilwaukee$116K
- Christopher WeberGermantown$113K
- Alejandro EismaWinnebago$84K
- Hammam ShereefMilwaukee$55K
- Brian SchreiberNeenah$49K
- Kaye-Eileen WillardRacine$47K
- Haroon ZubairWauwatosa$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.